Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling
Daniel C. Berwick(The Open University), Kirsten Harvey(University College London)
Cited by 52
Related Papers
Protective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity
|Frontiers in Molecular Neuroscience|2016|69
Dysregulated Wnt and NFAT signaling in a Parkinson’s disease LRRK2 G2019S knock-in model
|Scientific Reports|2024|17